Mitchell Lowenstein

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Annals of the Rheumatic Diseases · 2010 · 590 citations

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging…

Arthritis & Rheumatism · 2008 · 166 citations